The COVID-19 pandemic caused by the novel coronavirus SARS-CoV-2 has posed unprecedented challenges to global healthcare systems. While primarily recognized as a respiratory illness, emerging evidence suggests that SARS-CoV-2 can also lead to cardiovascular complications, particularly in patients with pre existing heart conditions. A recent experimental study conducted by Japanese scientists has shed light on the potential implications of SARS-CoV-2 infection on cardiac health, particularly in individuals with cardiomyopathy.
COVID-19 and Cardiomyopathy: Exposing the Linkage 1
Cardiomyopathy is a group of heart disorders characterized by impaired heart muscle function, which reduces the ability to pump blood effectively. The study conducted by the Riken Institute aimed to investigate the impact of SARS-CoV-2 infection on cardiac microtissues, which mimic human heart tissue composed of various cell types, including cardiomyocytes responsible for contraction, vascular endothelial cells, and mural cells.
Upon infecting cardiac microtissues with SARS-CoV-2, the researchers observed a reduction in tissue contractility during the acute phase of viral infection. Interestingly, even mild infections resulted in sustained viral presence for up to a month, indicating persistent infection. The study highlighted the potential risk of cardiac dysfunction and heart failure in patients with mild SARS-CoV-2 infection, particularly under additional cardiac stress.
The Role of ACE2 and Hypoxic Stress 1
According to recent research, the heart is more susceptible to SARS-CoV-2 infection due to the higher expression of angiotensin-converting enzyme 2 (ACE2) in cardiac tissue than in other organs. This enzyme serves as the entry point for the virus into epithelial cells, making the heart more vulnerable to viral infection. Additionally, when experimental models with persistent infection were exposed to hypoxic stress (a condition where the heart is deprived of oxygen), it further worsened cardiac dysfunction, highlighting the complex interplay between viral infection and cardiac health.
Clinical Implications and Global Impact 1
The study’s findings have significant clinical implications, particularly in the ongoing COVID-19 pandemic. Patients with existing heart failure are at an increased risk of developing severe COVID-19 symptoms and clinical outcomes, including myocardial infarction, cardiogenic shock, and heart failure. Furthermore, as demonstrated by previous studies, the long-term consequences of SARS-CoV-2 infection on cardiac health underscore the need for comprehensive monitoring and management of cardiovascular risks in COVID-19 patients.
Global Perspective: Variant JN.1 and Active Cases
According to the Union Ministry of Health and Family Welfare, India2 had 1,460 active cases of COVID-19 as of January 29, 2024. The emergence of a new variant of COVID-19, called JN.1, has caused worldwide concern, and India has reported 196 cases of this variant. Malaysia3, the Philippines4, and Thailand5 have also reported 11,920, 502, and 718 active cases of COVID-19, respectively, along with 320, 180, and 250 cases of the JN.1 variant. This highlights the increasing prevalence of the JN.1 variant and its potential impact on global health.
The Impact of SARS-CoV-2 on Cardiac Health: Conclusion 1
In conclusion, the experimental study provides valuable insights into the complex interplay between SARS-CoV-2 infection and cardiac health, particularly in patients with cardiomyopathy. The findings underscore the importance of early detection, comprehensive monitoring, and targeted interventions to mitigate the risk of cardiac dysfunction and heart failure in COVID-19 patients. Continued research efforts are essential to unravel the intricate mechanisms underlying the cardiovascular complications of COVID-19 and inform evidence-based strategies for patient management and care.
References
- SARS-CoV-2 can lead to heart impairment, experimental study finds [Internet]. www.downtoearth.org.in. [cited 2024 Jan 29]. Available from: https://www.downtoearth.org.in/news/health/sars-cov-2-can-lead-to-heart-impairment-experimental-study-finds-93662?utm_campaign=fullarticle&utm_medium=referral&utm_source=inshorts
- COVID-19 [Internet]. MyGov.in. 2020. Available from: https://www.mygov.in/covid-19
- Health M of. COVID-19 · Malaysia | KKMNOW [Internet]. data.moh.gov.my. 2023. Available from: https://data.moh.gov.my/dashboard/covid-19
- Thailand Coronavirus: 3,321 Cases and 58 Deaths – Worldometer [Internet]. www.worldometers.info. Available from: https://www.worldometers.info/coronavirus/country/thailand/
- Worldometer. Philippines Coronavirus: 3,246 Cases and 152 Deaths – Worldometer [Internet]. www.worldometers.info. Available from: https://www.worldometers.info/coronavirus/country/philippines/
About Docquity
If you need more confidence and insights to boost careers in healthcare, expanding the network to other healthcare professionals to practice peer-to-peer learning might be the answer. One way to do it is by joining a social platform for healthcare professionals, such as Docquity.
Docquity is an AI-based state-of-the-art private & secure continual learning network of verified doctors, bringing you real-time knowledge from thousands of doctors worldwide. Today, Docquity has over 400,000 doctors spread across six countries in Asia. Meet experts and trusted peers across Asia where you can safely discuss clinical cases, get up-to-date insights from webinars and research journals, and earn CME/CPD credits through certified courses from Docquity Academy. All with the ease of a mobile app available on Android & iOS platforms!
